Cardiac Arrest Clinical Trial
Official title:
Develop, Implement and Assess Effectiveness of Early Warning Score (EWS) for Moneragala District General Hospital
Rationale: Early detection and timely interventions are important determinants of clinical
outcome in people with acute illness. Adverse outcomes including unplanned transfer to
intensive care (ICU), cardiac arrest and death are usually preceded by acute physiological
changes manifesting as alterations in vital signs. Usage of early warning scores (EWS) based
on bedside vital sign observations may help early detection, improve outcome of patients and
reduce healthcare cost.
EWS which are effective in predicting deteriorating patients developed in high income
countries have been shown to lose sensitivity and specificity when applied to a low income
setting. It is imperative to explore the usefulness of EWSs in Sri Lanka. If the results are
positive, widespread adaptation of these scores can significantly contribute to improved
patient outcome, better utilization of ICU services and cost effective healthcare provision.
Objectives: To describe the demographic characteristics of cardiac arrest patients and the
availability of physiological variables for calculation various EWSs in DGH, Moneragala To
validate an early warning score suitable for patients at DGH, Moneragala To examine the
effectiveness of the selected EWS at improving pre-defined patient outcomes
Proposed methodology:
Study I: All clinical variables and patient characteristics of past two years collected
retrospectively from BHTs. Vital signs and laboratory measurements 24 and 48 hours before
cardio respiratory emergency and at admission to hospital will be extracted. The
availability of variables required for the calculation of various EWSs will be noted.
Study II: All consecutive inpatient admissions for three months to all units except
intensive care unit at DGH, Moneragala will be included to the study, prospectively. Data
will be collected from bed head tickets using pre-defined data sheets by nominated medical/
nursing officers daily. Demographic details and physiological data will be recorded on
admission to ward. Physiological data for seven EWS will be collected twice daily by these
medical/nursing officers.
Study III: Training will be given for the staff to identify patients getting worse using the
newly validated EWS. The outcome of this will be measured with information obtained from
Study II.
Ethical clearance obtained from the Ethics review Committee of the Faculty of Medicine,
University of Colombo (EC-15-034).
Introduction: Early detection and timely interventions are important determinants of
clinical outcome in people with acute illness. Adverse outcomes including unplanned transfer
to intensive care (ICU), cardiac arrest and death are usually preceded by acute
physiological changes manifesting as alterations in vital signs. Usage of early warning
scores (EWS) based on bedside vital sign observations may help early detection, improve
outcome of patients and reduce healthcare cost.
Effectiveness of EWS in predicting deterioration of seriously ill patients has been
demonstrated in high income countries (HICs). However, these scores developed in HICs have
been shown to lose sensitivity and specificity when applied to a low income setting. It is
imperative to explore the usefulness of EWSs in Sri Lanka. If the results are positive,
widespread adaptation of these scores can significantly contribute to improved patient
outcome, better utilization of ICU services and cost effective healthcare provision.
The study will take place in district general hospital (DGH) Moneragala, in Sri Lanka, a
lower middle income country (LMIC). The hospital has nearly 450 beds and over 800 staff
members serving over 50000 patients per year and approximately 500 cardiac arrests per year.
It has four medical wards, two surgical wards and 5 other wards. A wedge shaped
interventional study was designed to investigate whether a "setting tested" early warning
system protocol can be implemented in a rural district general hospital of a LMIC using a
local TTT model to reduce cardiac arrests and admissions to ICU.
Objectives
- To describe the characteristics, including EWS, of patients resuscitated at DGH,
Moneragala.
- To validate a suitable EWSs at DGH, Moneragala.
- To examine the effectiveness of the validated EWS as part of a training and
implementation bundle to reduce the incidence of cardiac arrests, ICU admissions and
mortality.
Methodology Study component 1- Retrospective study All clinical variables and patient
characteristics of past two years (01.04.2013-30.06.2015) collected retrospectively from
BHTs of all cardiac arrests (approximately 200) of DGH Moneragala. Vital signs and
laboratory measurements 24 and 48 hours before cardio respiratory emergency and at admission
to hospital will be extracted. The availability of variables required for the calculation of
various EWSs will be noted.
Data collection tool: Pre-defined data sheets. Study process: All clinical variables and
patient characteristics will be collected retrospectively from BHTs. Vital signs and
laboratory measurements 24 and 48 hours before cardio respiratory emergency and at admission
to hospital will be extracted. The availability of variables required for the calculation of
various EWSs will be noted.
Statistical analysis: Descriptive statistics will be used to describe the characteristics of
the resuscitated patients. Mean and standard deviation will be used for normally distributed
continuous variables while median and inter quartile ranges will be used for skewed
distributions of continuous variables. Count and percentages will be used for discrete
variables. The availability of physiological variables will also be illustrated using counts
and percentages.
Study component 2- The component two of the study is aimed at selecting and validating an
EWS that is capable of predicting cardiac arrest with high sensitivity and specificity A
prospective cohort design, conducted at all units of DGH, Moneragala (except ICU) on all
consecutive in-patient admissions for a period of 3 months.
Sample size: This phase will be used to determine the ability of EWSs to predict patient
outcome with regards to cardiac arrest, ICU admission and death. Assuming that the best
performing EWS will achieve an area under the ROC (AUROC) curve of .80 and an alpha of 0.05
with 80% power, comparison of an EWS that performs "worse" (AUROC curve = 0.80) will require
28 cardiac arrest patients. With a cardiac arrest rate of approximately 1% (cardiac
arrests/total admissions), and 56,000 admissions per year. this means that each EWS should
be performed on 2800 patients. Under the same assumptions, comparison of an EWS with an
AUROC curve = 0.70 will require n=108 patients with cardiac arrest; thus, 10,800 patients
should be tested with each EWS. With 56000 admissions per year 3 months of phase 2 will be
adequate for this.
Data collection tools: Data will be collected from bed head tickets using pre-defined data
sheets. Demographic details and physiological data will be recorded on admission to ward.
Physiological data will be collected twice daily by these medical/nursing officers.
National Early Warning Score (NEWS), Modified Early Warning Score (MEWS), Standardized Early
Warning Score (SEWS), Patient At Risk Score (PARS), Leeds Early Warning Score (LEWS), The
Assessment Score for Sick patient Identification and Step‐up in Treatment (ASSIST), Cardiac
Arrest Risk Triage (CART) and VitalpacTMEarly Warning Score (ViEWS) will be tested in this
phase to select the best performing one, as described below.
Statistical analysis: Data will be analyzed using STATA 13. Selection of the EWS will be
based on the discrimination (using area under the receiver operating characteristic curve),
calibration (using the Hosmer-Lemeshow Ĉ-statistic) and accuracy (using Brier score).
Study component 3- The purpose of this component is to examine the effectiveness of the
selected EWS at improving pre-defined patient outcomes.
This is an experimental step wedge design. Study setting and population: Same as study two
Study period: Twelve months Sample size: Currently, early detection of deterioration by
means of EWS prior to cardiac arrest is 0%. The current cardiac arrest team only attends to
patients when a cardiac arrest is detected. It was anticipate that, with the EWS identified
in Part 2 of the study, the early detection of cardiac arrests will increase to 50-75%. To
detect a difference of 50% in one ward, with 90% power and an alpha of 0.05, would require a
sample size of 15 cardiac arrest patients. The estimated cardiac arrest rate at this study
site is <1%. Assuming a cardiac arrest rate of approximately 1%, the selected EWS as part of
EWS should be performed on 1,500 patients.
This means the study will be powered to detect this in at least 7 of the 12 wards when
investigators implement the EWS over the 12 months it takes to recruit all wards. However
addition data collection for three months will enable (power) to detect this in almost all
the wards.
Data collection tools and study variables Patient data collected from bed head tickets using
pre-defined data sheets. Interviewer administered questionnaires will be used to assess the
success of the training for nurses and doctors. Successfulness of course delivery in each
section will be measured separately. Data sheets will be used to monitor the implementation
of the intervention and outcome measures.
Study variables include the same variables as in study 2. The indicators to monitor the
implementation of the intervention will also be gathered. Success of implementation will be
evaluated using process and outcome measures. These will include indicators to monitor the
implementation of the intervention (completeness of observations, use of EWS, appropriate
escalation by the nursing team) and outcome indicators (patients suffering cardiac arrests,
detected and missed by EWS, ICU admissions and in-hospital mortality). Data will also be
collected to monitor the success of the training programme (retention of knowledge).
Intervention and study process Introduce EWS: An EWS that is appropriate for use in the
study setting will be adapted and all participants will be educated on this.
Training of staff: The participating Doctors and Nurses from each ward will be trained on
early detection and management of clinically deteriorating patients based on the EWS
selected. The training will be implemented in a stepped wedge method with a new ward
absorbed in to the program monthly.
As each ward has the EWS introduced, an acute care training (ACT) course will be delivered
to its staff. The ACT course will comprise of preparation using dedicated e-learning
platform (http://nics-training.com/?page_id=403) followed by a 2-day structured, multi-modal
training package focused on acute care skills for ward nurses and doctors, comprising short
lectures, problem based learning and practical skills stations The ACT course will be
delivered to small groups, fortnightly by a faculty of local trainers (Doctors, nurse tutors
and nursing officers) who have received a five day preparatory train the trainer(TTT) course
led by experienced doctor and nurse trainers (part of investigators' study team) modeled on
previous efforts. As in phase 2, process and outcome data, will be collected by trained data
collectors.
Follow up: Formative and summative training assessments will be conducted on training
participants to measure the effectiveness of the programs, before and after training.
Coaching, support and feedback will be provided to the faculty every two months to ensure
maintenance of quality. Any issues faced by the staff during implementation will be
identified and appropriate remedial action will be taken.
The end points will be proportion of patients detected (and missed) by the system and the
number of unexpected cardiac arrests and ICU admissions.
Comparison of outcomes: The "at risk" population will be calculated as a proportion of those
who have actual cardiac arrests, and tested whether this will be at least 50% or 75% whereas
the value is now 0% (there is no systematic detection of at-risk patients currently, with
cardiac arrest team attending only after a declared cardiac arrest. This will be done for
each ward separately as well as to the group as whole. Matched group outcomes for ICU
admission rates, mortality and cardiac arrests will be compared. These will be assessed for
each ward and for the whole group before and after the EWS/RRS implementation. Wilcoxon
signed-rank test and McNemar test will be used to compare non parametric continuous and
discrete variables of matched group outcomes measured, respectively
Pre and post training: The impact of the training on the knowledge, skills and confidence of
the staff in the management of the deteriorating patient before and after the training will
be assessed, as above (appendix C, D and E).
Knowledge retention: Knowledge retention will be measured 3 months and 6 months after the
training.
Statistical analysis: Prevalence of unanticipated ICU admissions, cardiac arrests and
hospital mortality will be calculated for the hospital overall, as well as by ward (using
the total number of admissions as the denominator), before and after implementation of the
EWS selected from component 2 of the study. The effectiveness of the EWS system will be
assessed by comparison of the proportion of cardiac arrest cases that are identified early
before and after use of the EWS. Risk ratios with 95% confidence intervals will be
calculated with shared frailty specified for a ward to account for any within ward
clustering. The formative and summative assessments will be used to compare, in a paired
manner, the effect of the training program on ward staff. The outcome analysis and
statistical tests used to compare outcomes before and after implementing the EWS is
described in section 3.5 comparison of outcomes
Ethical clearance obtained from the Ethics review Committee of the Faculty of Medicine,
University of Colombo (EC-15-034).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06048068 -
Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events
|
N/A | |
Recruiting |
NCT05558228 -
Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
|
||
Completed |
NCT03685383 -
Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
|
N/A | |
Completed |
NCT04619498 -
Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT02352350 -
Lactate in Cardiac Arrest
|
N/A | |
Completed |
NCT03024021 -
Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
|
||
Completed |
NCT02275234 -
Care After Resuscitation
|
||
Completed |
NCT02247947 -
Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
|
||
Completed |
NCT01944605 -
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
|
N/A | |
Completed |
NCT01936597 -
Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage
|
N/A | |
Completed |
NCT01972087 -
Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest
|
N/A | |
Active, not recruiting |
NCT01239420 -
Norwegian Cardio-Respiratory Arrest Study
|
||
Completed |
NCT00878644 -
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial
|
Phase 3 | |
Completed |
NCT00880087 -
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial
|
N/A | |
Completed |
NCT01191736 -
Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice
|
N/A | |
Completed |
NCT00729794 -
Vasopressin, Epinephrine, and Steroids for Cardiac Arrest
|
Phase 3 | |
Recruiting |
NCT00441753 -
Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
|
N/A | |
Completed |
NCT00347477 -
Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest
|
Phase 3 |